KNG1 and COVID-19: In comparison with HC, patients with COVID-19 presented elevated plasma concentrations of HK (Figure 1A), a compound that is delivered to the blood by the liver under basal conditions and that could be released by other tissues, such as alveoli epithelium, under inflammatory conditions (27).